Health Guide » China

World Cancer Conference will be held in China in August

lovehealth — Thu, 27 May 2010 15:40:12 +0000

21th International Union Against Cancer World Cancer Conference will be held in August this year, held in Shenzhen, China.

This is the first time the World Cancer Conference held in China, the International Union Against Cancer will be the largest, highest level, the most widely influential academic conference world-class cancer.

The theme is: prevent preventable diseases, treatment of patients can be treated by the system to fruition.

China pharmaceutical prices reform recent and long-term goals

lovehealth — Tue, 24 Nov 2009 08:07:11 +0000

According to the China national development and reform commission, ministry of public health and human resource ministry issued jointly files by Nov.23 , until 2011, Chinese medicine in order to gradually improve the market price, the price is reasonable, drug tends to medical service price obviously alleviate structural contradictions, By 2020, pharmaceutical prices can objectively reflect the changes in production and service cost and market supply and demand.

To implement the CPC central committee and the state council on deepening the reform of medical care system and spirit of the three departments issued by the reform of drugs and medical service price forming mechanism of the opinions of the pharmaceutical prices reform, put forward the immediate and long-term goals.

The opinions of definitely put forward by 2020, to establish scientific and reasonable price forming mechanism of medical and pharmaceutical price management system.

Novartis will invest one billion U.S. dollars in China

lovehealth — Tue, 03 Nov 2009 18:06:39 +0000

Novartis will invest one billion U.S. dollars, to build in China’s largest pharmaceutical R & D base, the move highlights the developing markets, the importance of the company’s future growth.

Novartis and other pharmaceutical manufacturers are keen on the development of China and other emerging markets, mainly because it faces slower growth, as well as the loss of exclusivity on key products position, including Novartis’s best-selling blood pressure drug Diovan.

Novartis said it will invest 250 million U.S. dollars used in Changshu (Changshu) construction of a second R & D and production facilities.

China developed a long-range health of rescue systems

lovehealth — Sun, 25 Oct 2009 11:49:10 +0000

“Bian Que flying save ” long-range health of rescue system consists of Beijing IVT’s patented technology using a number of wireless communications combined with modern medical technology research and development. It consists of health, mobile phones, digital medical equipment, mobile phones and fixed networks, call center, network platform, etc., and is a prevention, monitoring, positioning, crying for help in one of the long-range health of rescue service system.

The use of this system, the user can real-time, non-invasive measurement of blood pressure, electrocardiogram, pulse, blood oxygen, and vital signs of these representatives in special health survey findings indicate that mobile phones, through GPRS or SMS automatically sent to the call center’s personal e – Health Records library can also be automatically sent to friends and relatives bound phone, easy to relatives, friends and call center users to grasp the state of health.

Dr. Gao Qiang, CEO of IVT Corporation, said, “Bian Que flying save the” long-range health alarm system will not only real-time monitoring in patients with health indicators, establish a lifetime health records, but also able to provide emergency call service and home location-based services is the use of wireless communication systems and modern medical technology combined results.

Sanofi – Aventis Pharma companies enter the China non-prescription drug market

lovehealth — Sun, 25 Oct 2009 07:50:37 +0000

October 24, Europe’s largest pharmaceutical company Sanofi – Aventis and Hangzhou Minsheng Pharmaceutical Co., Ltd. signed a letter of intent, the two sides will jointly set up a new consumer medical products joint venture.

According to Sanofi – Aventis China headquarters in Shanghai said the new joint venture will focus on production and operation of vitamins and minerals products.

Minsheng Pharmaceutical’s “21 Jin he was” for many years among the Chinese vitamin market, sales of single items first, by virtue of this flagship brand, the people’s livelihood in the non-prescription drug market has considerable strength. Sanofi – Aventis, said the new joint venture will be the company to enter China’s non-prescription drug market, a strategic platform.

Sanofi – Aventis is a world leading multinational pharmaceutical companies, the Group’s headquarters in Paris. China Minsheng Pharmaceutical is one of the earliest established in Western pharmaceutical companies, with 80 years of specialty pharmaceutical history.